Counterpressure Maneuvers for Fainting
Trial Summary
Yes, if you are taking any cardiovascular acting medications or medications for orthostatic syncope, you will be excluded from the study.
The available research does not provide any direct data supporting the effectiveness of Counterpressure Maneuvers for Fainting. The studies focus on muscle activation in different contexts, such as gluteus maximus activation during chair-rise in stroke patients or muscle activity during sit-to-stand movements. None of these studies directly address the use of Counterpressure Maneuvers for Fainting or compare it to other treatments for fainting.
12345The provided research abstracts do not directly address the safety data for counterpressure maneuvers for fainting. They focus on muscle activation and contractility in various contexts, such as gluteal muscle contraction, abdominal muscle strength, and motor strategies for movements like sitting and squatting. None of these studies specifically evaluate the safety of counterpressure maneuvers or related techniques for fainting.
14678Eligibility Criteria
This trial is for English-speaking children aged 6-18 with recurrent fainting due to vasovagal syncope or POTS, having fainted at least twice in the last year. It excludes those not fully vaccinated against COVID-19, with seizure disorders, cardiovascular diseases, pregnancy, disabilities affecting test completion, on certain medications for syncope or heart issues.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Testing Session
Participants attend a single testing session to perform various counterpressure maneuvers and cardiovascular tests.
Follow-up
Participants are monitored for any adverse effects or changes in cardiovascular responses post-testing.